Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Hualong Biological Pharmaceutical, commonly known as Hualong Bio, is a specialized biopharmaceutical company based in Beijing, China. Established in 1993, it is a subsidiary of the China Meheco Group and focuses on the research, development, and large-scale production of genetic engineering drugs. The company's product portfolio is centered on recombinant proteins and peptides, with flagship products including recombinant human growth hormone (Somatropin) and salmon calcitonin. Hualong Bio operates advanced GMP-certified manufacturing lines for injections and lyophilized powders. Its therapeutic focus spans endocrinology, oncology, and immunology, serving as a key supplier in the Chinese domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hualong Bio.